Denali Therapeutics at PEGS Europe 2026

Nov 16–19, 2026 Lisbon, Portugal ~1.5k attendees Website

Denali Therapeutics brings 3 presentations to PEGS Europe 2026 in Lisbon. Its program centres on carrying large molecules into the brain, using transferrin receptor transport vehicles and dual targeting with CD98hc. It also covers delivering therapeutic enzymes to the central nervous system and peripheral tissues.

OrganizationPEGS Europe 2026 Attendance
Denali Therapeutics
South San Francisco, CA
denalitherapeutics.com
Biotech
Develops medicines for neurodegenerative and lysosomal diseases, using its Transport Vehicle platform to carry biologics across the blood–brain barrier.
Talk
Thu Nov 19
11:45am–12:15pm
Dual Targeting of Transferrin Receptor and CD98hc Enhances Brain Exposure of Large Molecules
Engineering the Next Generation of Bispecific Antibodies
Talk
Thu Nov 19
2:05pm–2:35pm
Panel
Thu Nov 19
3:35pm–4:15pm

Explore the full PEGS Europe 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Lisbon. Leave your work email and we’ll be in touch.

Privacy

Download the full PEGS Europe 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Denali Therapeutics

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by PEGS Europe or its organizers. Submit a correction